Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birol Emir

Showing results (41-50 of 110) with videos related to

Pageof 11
Sort By:
The Clinical Journal of Pain|March 11, 2015
Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With FibromyalgiaCharles E Argoff, Andrew Clair, Birol Emir, et al.
Journal of Pain Research|June 20, 2015
Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical recordsBirol Emir, Elizabeth T Masters, Jack Mardekian, et al.
Journal of Pain Research|March 19, 2015
Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilizationElizabeth T Masters, Jack Mardekian, Birol Emir, et al.
Pain Medicine (Malden, Mass.)|March 19, 2008
Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trialBrett R Stacey, Robert H Dworkin, Kevin Murphy, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 28, 2013
A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic painRainer Freynhagen, Michael Serpell, Birol Emir, et al.
Cancer Science|March 3, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancerYasushi Goto, Takehito Shukuya, Ai Murata, et al.
Journal of the American Geriatrics Society|May 22, 2003
Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burdenHoward Feldman, Serge Gauthier, Jane Hecker, et al.
Hepatology Communications|April 2, 2022
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learningMazen Noureddin, Fady Ntanios, Deepa Malhotra, et al.
Future Oncology (London, England)|August 22, 2023
Effectiveness of crizotinib in patients with <i>ROS1</i>-positive non-small-cell lung cancer: real-world evidence in JapanNaoyuki Nogami, Atsushi Nakamura, Naoko Shiraiwa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare DatabaseJonathan F Brozat, Fady Ntanios, Deepa Malhotra, et al.
Pageof 11

Showing results (41-50 of 110) with videos related to

Sort By:
Pageof 11
The Clinical Journal of Pain|March 11, 2015
Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With FibromyalgiaCharles E Argoff, Andrew Clair, Birol Emir, et al.
Journal of Pain Research|June 20, 2015
Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical recordsBirol Emir, Elizabeth T Masters, Jack Mardekian, et al.
Journal of Pain Research|March 19, 2015
Electronic medical record data to identify variables associated with a fibromyalgia diagnosis: importance of health care resource utilizationElizabeth T Masters, Jack Mardekian, Birol Emir, et al.
Pain Medicine (Malden, Mass.)|March 19, 2008
Pregabalin in the treatment of refractory neuropathic pain: results of a 15-month open-label trialBrett R Stacey, Robert H Dworkin, Kevin Murphy, et al.
Pain Practice : the Official Journal of World Institute of Pain|November 28, 2013
A comprehensive drug safety evaluation of pregabalin in peripheral neuropathic painRainer Freynhagen, Michael Serpell, Birol Emir, et al.
Cancer Science|March 3, 2023
Real-world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK-positive non-small-cell lung cancerYasushi Goto, Takehito Shukuya, Ai Murata, et al.
Journal of the American Geriatrics Society|May 22, 2003
Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burdenHoward Feldman, Serge Gauthier, Jane Hecker, et al.
Hepatology Communications|April 2, 2022
Predicting NAFLD prevalence in the United States using National Health and Nutrition Examination Survey 2017-2018 transient elastography data and application of machine learningMazen Noureddin, Fady Ntanios, Deepa Malhotra, et al.
Future Oncology (London, England)|August 22, 2023
Effectiveness of crizotinib in patients with <i>ROS1</i>-positive non-small-cell lung cancer: real-world evidence in JapanNaoyuki Nogami, Atsushi Nakamura, Naoko Shiraiwa, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 19, 2023
NAFLD and NASH are obesity-independent risk factors in COVID-19: Matched real-world results from the large PINC AI™ Healthcare DatabaseJonathan F Brozat, Fady Ntanios, Deepa Malhotra, et al.
Pageof 11